RxDoctor Payments Data

Trina Tridico, MD

Family Medicine · Hickory, NCNPI 1376679001

Payments from drug & device makers

$1,050in general payments, 2019–2025

Across 68 payments — averaging $15.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$201
  • Novo Nordisk$144
  • GSK$127
  • Pfizer$107
  • Abbott$90
  • Phathom Pharmaceuticals, Inc.$61
  • plus $320 from 13 others

What the payments were for

  • Food & beverage$1,050100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,050 in reported general payments places this provider in the 70th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$108,747
Medicare patients
171
Services billed
1,884

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide158$171,596
MounjaroTirzepatide76$99,712
EliquisApixaban87$80,487
TradjentaLinagliptin61$52,813
Tresiba Flextouch U-200Insulin Degludec14$22,087
Tresiba Flextouch U-100Insulin Degludec45$21,704
FarxigaDapagliflozin Propanediol27$21,126
JardianceEmpagliflozin19$20,886
Breo ElliptaFluticasone/Vilanterol31$16,621
JanuviaSitagliptin Phosphate12$16,589
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$14,659
LinzessLinaclotide21$13,223
NexiumEsomeprazole Magnesium19$10,950
Repatha SureclickEvolocumab15$10,445
MyrbetriqMirabegron13$9,636

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$144$171,596158 claims
Lilly USA, LLCMounjaro$42$99,71276 claims
PfizerEliquis, Premarin$107$83,81499 claims
Boehringer IngelheimTradjenta, Jardiance$42$73,69980 claims
AstraZenecaFarxiga, Nexium, Symbicort$201$39,93480 claims
GSKBreo Ellipta, Trelegy Ellipta$127$31,28054 claims
AbbVieLinzess, Synthroid$11$18,22075 claims
Astellas Pharma US IncMyrbetriq$52$9,63613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Hickory

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →